In vitro experiments, the activation of NF-κB signaling pathway is inhibited mainly by gene silencing technology, and the molecular mechanism of NF-κB signaling pathway in osteosarcoma is revealed. This evidence concerns the gene NFKB1 and osteosarcoma.